27/08/2026
MYTH: There isn’t research supporting the safety of mesenchymal stem cell therapy.
FACT: Human umbilical cord tissue-derived mesenchymal stem cells (hUCT-MSCs) have been evaluated for safety in published clinical research.
For more than two decades, Stem Cell Institute has been committed to advancing stem cell therapy through research and clinical experience. Published studies have evaluated the safety and tolerability of mesenchymal stem cells, including MSCs derived from human umbilical cord tissue.
MSCs also have unique immunomodulatory properties that continue to be an important area of scientific research.
Not all stem cells—or stem cell therapies—are the same. Understanding the type and source of cells being used, as well as the research behind them, is an important part of making an informed decision.